AEON
AEON Biopharma·AMEX
--
--(--)
--
--(--)
6.95 / 10
Outperform
Analyst consensus is overwhelmingly bullish, with a single Strong Buy rating and a 100% historical win rate. Fund‑flow score is 6.97/10, showing solid inflows from small and medium investors but negative trends for large blocks. Sentiment remains positive.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-10-08
InstitutionAegis Capital
Times predicted1
Historical Win Rate100.0%
What is the analyst consensus for AEON?
- AEON holds a Bullish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 6.95/10 (Outperform).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
